Medical News & Innovators

Despite the potential losses from the British departure, leaders in the UK healthcare and technology industries have made it clear that innovation in the field of medicine and healthcare must continue.

The Cambridge-based startup is aimed at furthering technologies in "immuno-oncology" – drugs that tackle the immune system to better attack cancer cells.

Biotechnology company PharmaMar develops innovative marine organism-derived anticancer drugs. 

CMS collected readmission rate data on heart attack patients over a two-year period. Compared to the readmission rate national average of 17 percent, Genesis Medical Center is excelling greatly in patient treatment and rehabilitation.

Medtronic has been investing in companies that manufacture less-invasive surgical devices. This signals the company's intention to adapt its business to healthcare trends of implantable devices and wearables.

Colorado Medical Waste’s technique proves to be a game-changer for the challenge of medical waste disposal that the health industry has been dealing with for decades.

While it is well established that central fatigue due to strenuous exercise affects limb movement, researchers wanted to find out if this also impacts other motor systems, such as eye movement.

In a test during a scientific meeting, the AI system has shown to boost human accuracy of detecting breast cancer to 99.5 percent.

Michael M. Merzenich, PhD was recognized among others for pioneering work on the brain’s “plasticity” – its remarkable ability to rewire itself in response to new conditions, a capacity that underlies learning and offers the potential for retraining the brain in neurodevelopmental disorders and diseases

Dana-Farber Cancer Institute scientists report that they have been able to chemically blindside a mutant enzyme critical to lung cancer cells. The study was published in the journal Nature.